ArticleJournal for immunotherapy of cancer2025

JAK inhibitors for the treatment of life-threatening and refractory immune-related adverse events secondary to immune checkpoint inhibitors: a prospective cohort study.

Rami Habib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.